Literature DB >> 8219299

Ear dominance for nonsense-syllable recognition ability in sensorineural hearing-impaired children: monaural versus binaural amplification.

H Hattori1.   

Abstract

The purpose of this investigation was to determine whether an auditory-deprivation/dominant-ear effect associated with nonalternating monaural amplification is present in children. Subjects were 35 children with bilateral symmetric, moderately severe to profound, sensorineural hearing impairment. Seventeen were fitted with nonalternating monaural amplification and 18 were fitted with binaural or alternating monaural amplification. Taped speech stimuli consisted of 20 nonsense syllables. The mean age at which subjects were fitted with amplification was 4.8 years for the monaural group and 4.9 years for the binaural group. The mean period between hearing-aid fitting and the initial test was 4.1 years for the monaural group vs. 3.4 years for the binaural group. The mean interval between the age at retest and the age at which the subject was fitted with amplification was 15.8 years for the monaural group and 13.9 years for the binaural group. Results revealed a significant difference in the mean interaural difference score (IDS) for nonsense-syllable recognition (NSR) at the initial test and at the retest between group A and group B. The results also revealed that the progression from initial test to retest in the IDS for NSR was 10.7 percent for the nonalternating monaurally fitted subjects as compared with -3.3 percent for the binaurally or alternating monaurally fitted subjects. Results are discussed in relation to the theories of auditory deprivation and ear dominance.

Entities:  

Mesh:

Year:  1993        PMID: 8219299

Source DB:  PubMed          Journal:  J Am Acad Audiol        ISSN: 1050-0545            Impact factor:   1.664


  10 in total

1.  Curriculum for graduate courses in amplification.

Authors:  C V Palmer
Journal:  Trends Amplif       Date:  1998-03

2.  A Survey of Deaf Mutes.

Authors:  R S Bhadauria; S Nair; D K Pal
Journal:  Med J Armed Forces India       Date:  2011-07-21

3.  Benefits of Cochlear Implantation in Childhood Unilateral Hearing Loss (CUHL Trial).

Authors:  Kevin D Brown; Margaret T Dillon; Lisa R Park
Journal:  Laryngoscope       Date:  2021-09-20       Impact factor: 2.970

4.  Cochlear implantation in nontraditional candidates: preliminary results in adolescents with asymmetric hearing loss.

Authors:  Jamie H Cadieux; Jill B Firszt; Ruth M Reeder
Journal:  Otol Neurotol       Date:  2013-04       Impact factor: 2.311

Review 5.  Amplification considerations for children with minimal or mild bilateral hearing loss and unilateral hearing loss.

Authors:  Sarah McKay; Judith S Gravel; Anne Marie Tharpe
Journal:  Trends Amplif       Date:  2008-03

Review 6.  Binaural-bimodal fitting or bilateral implantation for managing severe to profound deafness: a review.

Authors:  T Y C Ching; E van Wanrooy; H Dillon
Journal:  Trends Amplif       Date:  2007-09

7.  A case study assessing the auditory and speech development of four children implanted with cochlear implants by the chronological age of 12 months.

Authors:  Birgit May-Mederake; Wafaa Shehata-Dieler
Journal:  Case Rep Otolaryngol       Date:  2013-02-20

Review 8.  Central plasticity and dysfunction elicited by aural deprivation in the critical period.

Authors:  Zhiji Chen; Wei Yuan
Journal:  Front Neural Circuits       Date:  2015-06-02       Impact factor: 3.492

Review 9.  Language disorders in children with unilateral hearing loss: a systematic review.

Authors:  Maria Renata José; Maria Fernanda Capoani Garcia Mondelli; Mariza Ribeiro Feniman; Simone Aparecida Lopes-Herrera
Journal:  Int Arch Otorhinolaryngol       Date:  2013-12-03

10.  Which Patients With a Unilateral Hearing Aid for Symmetric Sensorineural Hearing Loss Have Auditory Deprivation?

Authors:  Hyun Jin Lee; Jeon Mi Lee; Gina Na; Young Min Moon; Chan Lee; Jinsei Jung
Journal:  Clin Exp Otorhinolaryngol       Date:  2019-07-16       Impact factor: 3.372

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.